Characteristic | No. (%) of patients n = 48 239 |
---|---|
Age group, yr | |
18–24 | 2951 (6.1) |
25–29 | 3438 (7.1) |
30–34 | 3959 (8.2) |
35–39 | 4874 (10.1) |
40–44 | 6535 (13.5) |
45–49 | 8007 (16.6) |
50–54 | 7641 (15.8) |
55–59 | 4875 (10.1) |
60–64 | 2266 (4.7) |
65–69 | 1248 (2.6) |
70–74 | 847 (1.8) |
75–79 | 776 (1.6) |
80–84 | 504 (1.0) |
85–105 | 318 (0.7) |
Sex | |
Male | 30 763 (63.8) |
Female | 17 476 (36.2) |
Residence | |
Rural | 5087 (10.5) |
Urban | 43 007 (89.2) |
Missing | 145 (0.3) |
Income quintile | |
Q1 (lowest) | 16 957 (35.2) |
Q2 | 10 761 (22.3) |
Q3 | 8222 (17.0) |
Q4 | 6777 (14.0) |
Q5 (highest) | 5030 (10.4) |
Missing | 492 (1.0) |
Immigrant | 4924 (10.2) |
Hepatitis C virus genotype | |
G1 | 19 572 (40.6) |
G2 | 3468 (7.2) |
G3 | 5898 (12.2) |
G4 | 501 (1.0) |
G5 | 41 (0.1) |
G6 | 152 (0.3) |
Mixed | 290 (0.6) |
Missing | 18 317 (38.0) |
Health state at diagnosis | |
No cirrhosis | 43 568 (90.3) |
Compensated cirrhosis | 2414 (5.0) |
Decompensated cirrhosis | 859 (1.8) |
Hepatocellular carcinoma | 79 (0.2) |
Both decompensated cirrhosis and hepatocellular carcinoma | 27 (0.1) |
Liver transplantation | 108 (0.2) |
Terminal, liver-related | 504 (1.0) |
Terminal, non–liver-related | 680 (1.4) |
Comorbidity, Aggregated Diagnosis Groups score | |
0 | 1287 (2.7) |
1–3 | 14 321 (29.7) |
4–7 | 20 017 (41.5) |
8–10 | 8037 (16.7) |
≥ 11 | 4577 (9.5) |